United States Prosthetic Heart Valves Market Outlook to 2025

  • ID: 4516283
  • Report
  • Region: United States
  • 64 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Edwards Lifesciences Corp
  • Medtronic Plc
  • MORE
United States Prosthetic Heart Valves Market Outlook to 2025

Summary

The author's new report, "United States Prosthetic Heart Valves Market Outlook to 2025", provides key market data on the United States Prosthetic Heart Valves market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Tissue Heart Valves, Transcatheter Heart Valves and Mechanical Heart Valves.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Prosthetic Heart Valves market segments - Tissue Heart Valves, Transcatheter Heart Valves and Mechanical Heart Valves.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Prosthetic Heart Valves market.
  • Global corporate-level profiles of key companies operating within the United States Prosthetic Heart Valves market.
  • Key players covered include Abbott Laboratories, Medtronic plc. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Edwards Lifesciences Corp
  • Medtronic Plc
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Prosthetic Heart Valves Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Prosthetic Heart Valves Market, United States
3.1 Prosthetic Heart Valves Market, United States, Revenue ($m), 2015-2025
3.1.1 Mechanical Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Tissue Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Transcatheter Heart Valves Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025
3.2.1 Mechanical Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Tissue Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Transcatheter Heart Valves Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2025
3.4 Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in United States, Prosthetic Heart Valves Market
4.1 Edwards Lifesciences Corp
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview

5 Prosthetic Heart Valves Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.1.1 LivaNova Acquires Remaining 51% Stake in Caisson Interventional
6.2 Venture Financing
6.2.1 Hancock Jaffe Lab Raises USD1 million in Venture Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency
7.1.2 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
7.1.3 Jun 15, 2017: FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus
7.1.4 May 18, 2017: Edwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020
7.2 Financial Announcements
7.2.1 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
7.2.2 Jan 23, 2018: Glytec's Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology
7.2.3 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting
7.2.4 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
7.2.5 Oct 26, 2017: Bicycle Therapeutics to Present Preclinical Data on Lead Molecule BT1718 at the AACR-NCI-EORTC International Cancer Conference
7.2.6 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
7.2.7 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference
7.2.8 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine
7.2.9 Aug 15, 2017: CareRay Exhibits At FIME 2017
7.2.10 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
7.2.11 Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients
7.2.12 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
7.3 Government and Public Interest
7.3.1 Dec 15, 2017: Oxford Immunotec and QIAGEN Resolve Patent Infringement Lawsuit involving QuantiFERON-TB Gold Plus
7.4 Legal And Regulatory
7.4.1 Nov 03, 2017: Neovasc Provides Litigation Update
7.5 Product News
7.5.1 Nov 08, 2017: Mechanical heart valve often the safest choice
7.5.2 Oct 04, 2017: Study shows low mortality, stroke risks for minimally invasive aortic valve replacements
7.5.3 May 18, 2017: Wyss Institute: Engineering heart valves for the many
7.6 Strategy And Business Planning
7.6.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
7.6.2 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2020
Table 10: Prosthetic Heart Valves Market, United States, Volume (Units), 2021-2025
Table 11: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2020
Table 12: Mechanical Heart Valves Market, United States, Volume (Units), 2021-2025
Table 13: Tissue Heart Valves Market, United States, Volume (Units), 2015-2020
Table 14: Tissue Heart Valves Market, United States, Volume (Units), 2021-2025
Table 15: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2020
Table 16: Transcatheter Heart Valves Market, United States, Volume (Units), 2021-2025
Table 17: Prosthetic Heart Valves Market, United States, Average Price ($), 2015-2020
Table 18: Prosthetic Heart Valves Market, United States, Average Price ($), 2021-2025
Table 19: Prosthetic Heart Valves Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Prosthetic Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Prosthetic Heart Valves Market Pipeline Products
Table 22: LivaNova Acquires Remaining 51% Stake in Caisson Interventional
Table 23: Hancock Jaffe Lab Raises USD1 million in Venture Financing
Table 24: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures
Figure 1: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Mechanical Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Tissue Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Transcatheter Heart Valves Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Prosthetic Heart Valves Market, United States, Volume (Units), 2015-2025
Figure 6: Mechanical Heart Valves Market, United States, Volume (Units), 2015-2025
Figure 7: Tissue Heart Valves Market, United States, Volume (Units), 2015-2025
Figure 8: Transcatheter Heart Valves Market, United States, Volume (Units), 2015-2025
Figure 9: Prosthetic Heart Valves Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Edwards Lifesciences Corp
  • Medtronic Plc
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll